CLDX
Celldex Therapeutics Inc
29.70$
+2.3%
vs. previous close
Closing price · As of: Nov 3, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +52.8% | +23.8% | +87.8% | -25.2% | -62.5% | +107.6% | -37.3% | -49.3% | +192.0% | +2.0% | -78.6% | |
| – | +17.9% | +2,443.7% | -5.7% | -30.9% | -35.8% | -0.3% | +25.3% | +54.3% | +43.5% | +38.6% | – | |
| – | +694.1% | -6,583.3% | – | – | – | – | – | – | – | – | – | |
| – | -4.0% | +2.6% | -6.4% | -30.9% | -35.8% | -5.0% | +40.2% | +44.8% | +43.5% | +38.6% | +49.9% | |
| – | +64.1% | +6.3% | -30.5% | -22.9% | -19.9% | -6.3% | +41.7% | +32.7% | +13.7% | +24.7% | +13.6% | |
| – | -71.6% | +8.1% | +1.1% | +161.2% | -84.0% | +77.2% | -20.0% | +56.5% | +22.9% | -11.2% | +649.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +846.0% | -100.0% | – | -99.4% | +2,497.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -72.8% | -5,658.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.